Overview
A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Indication
For induction and maintenance of general anesthesia.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/06/03 | Phase 4 | Not yet recruiting | |||
2024/10/03 | Phase 3 | Recruiting | |||
2024/10/03 | Not Applicable | Completed | |||
2024/05/17 | Phase 2 | Recruiting | |||
2024/03/15 | Not Applicable | Recruiting | University Hospital, Grenoble | ||
2024/02/09 | Not Applicable | Active, not recruiting | |||
2023/08/28 | Phase 2 | Recruiting | |||
2023/08/15 | Early Phase 1 | Recruiting | Our Lady of the Lake Hospital | ||
2023/05/22 | Phase 3 | Recruiting | |||
2023/04/26 | N/A | Not yet recruiting | Hopital of Melun |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Piramal Critical Care Inc | 66794-011 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 2/1/2023 | |
| Baxter Healthcare Corporation | 10019-360 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 4/27/2017 | |
| Piramal Critical Care Inc | 66794-020 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 2/16/2023 | |
| Piramal Critical Care Inc | 66794-019 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 2/9/2023 | |
| Halocarbon Life Sciences, LLC | 12164-012 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 3/27/2020 | |
| Piramal Critical Care, Inc. | 66794-017 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 1/11/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| AERRANE INHALATION ANAESTHETIC | SIN08670P | SOLUTION | 100% | 4/19/1996 | |
| ISOFLURANE INHALATION | SIN07914P | SOLUTION | 100% | 11/15/1994 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| AERRANE isoflurane 1mL/mL inhalation bottle | 55105 | Medicine | A | 7/17/1996 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| ISOFLURANE USP | technilab pharma inc. | 02237684 | Liquid - Inhalation | 100 % | 1/21/1999 |
| ISOFLURANE USP | 02032384 | Liquid - Oral
,
Inhalation | 99.9 % | 12/31/1993 | |
| ISOFLURANE USP | fresenius kabi canada ltd | 02231929 | Liquid - Inhalation | 99.9 % | 11/14/1997 |
| FORANE LIQ INH | ohmeda pharmaceutical products, division of boc canada limited | 02056666 | Liquid - Inhalation | 100 % | 12/31/1994 |
| ISOFLURANE USP | halocarbon laboratories, a division of halocarbon products corp | 02241315 | Liquid - Inhalation | 99.9 % | 11/3/2004 |
| FORANE | baxter corporation | 02188856 | Liquid - Inhalation | 100 % | 12/31/1996 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| SEDACONDA 100 % LIQUIDO PARA INHALACION DEL VAPOR | Sedana Medical Ab (Publ) | 86293 | LÍQUIDO PARA INHALACIÓN DEL VAPOR | Uso Hospitalario | Commercialized |
| AERRANE 100% LÍQUIDO PARA INHALACIÓN DEL VAPOR | Baxter S.L. | 60378 | SOLUCIÓN PARA INHALACIÓN DEL VAPOR | Uso Hospitalario | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.